Opko Opko Health Q1 Revenues More Than Double Due to COVID-19 Test Demand The company reported revenues of $545.2 million compared to $211.5 million in the year-ago quarter, primarily driven by COVID-19 testing. BioReference Labs Inks Deal to Provide Rapid PCR, Point-of-Care COVID-19 Testing for MLB The firm is using Mesa Biotech's Accula system for the testing, beginning Thursday, the start of the 2021 MLB season. Opko Health Q4 Revenues More Than Double Thanks to COVID-19 Testing The company's service revenues increased 157 percent to $457.9 million due to significant COVID-19 testing volumes, slightly offset by lower base business volumes. Opko Health Q3 Revenues Up 87 Percent The firm's subsidiary BioReference Laboratories performed 3.5 million COVID-19 PCR tests and 300,000 serology tests during the quarter. As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit While the market ditched shares of many other diagnostics firms, analysts said the reaction was overblown, particularly in the case of Quidel and molecular diagnostics players. Aug 12, 2020 GeneDx Inks Neonatal Genomic Services Deal With Pediatrix Medical Group Mar 14, 2020 Trump Administration Highlights Role of Private Sector in Effort to Increase Coronavirus Testing Mar 5, 2020 Commercial Labs Step up Coronavirus Test Efforts After FDA Guidance Jan 16, 2020 JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More Dec 6, 2019 Local Coverage Determinations Roundup: Transplant Genomics, Opko Health Jan 12, 2018 GeneDx, Radboud UMC Collaborate on Research Into Neurodevelopmental Disorders Nov 22, 2017 Longstanding Genetic Testing Website GeneTests Closing Sep 19, 2017 BioReference, The Garage Form Alliance to Advance Patient Care Jun 7, 2017 UC Health to Have Expanded Access to GeneDx Tests Mar 10, 2017 Opko Hopes Medicare Decision Will Help Drive Adoption of 4Kscore Prostate Cancer Dx Premium Nov 7, 2016 Opko Q3 Revenues Up 108 Percent on Strength of BioReference Sales Oct 10, 2016 GeneDx Launches Prenatal Exome Sequencing Test, Plans to Expand Into New Dx Areas Premium Oct 7, 2016 MDx Experts See Need for More Test Integration in Providing Comprehensive Cancer Diagnoses Premium May 9, 2016 Opko Q1 Revenues Up Nearly Ninefold Nov 10, 2015 Opko Posts Big Q3 Revenue Gain on Acquisitions Aug 20, 2015 Opko Completes $1.47B Buy of Bio-Reference Aug 19, 2015 Opko Signs Contract With Three Insurers Jul 2, 2015 Opko's Acquisition of Bio-Reference Labs Passes US Antitrust Review Jun 8, 2015 Bio-Reference Q2 Revenues Grow 11 Percent Jun 4, 2015 Opko Health to Buy Bio-Reference Labs for $1.47B Load More Breaking News JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems Top Five Articles on GenomeWeb Last Week: Danaher, Becton Dickinson, 23andMe, and More Berry Oncology, Alibaba Health Partner to Offer Early Cancer Screening, Health Services Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More The Scan Renewed Gain-of-Function Worries The New York Times writes that the pandemic is renewing concerns about gain-of-function research. Who's Getting the Patents? A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports. Other Uses CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2. PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.